DE602007005041D1 - Verfahren zur Behandlung von Entzündungserkrankungen mit Maracujaextrakten - Google Patents

Verfahren zur Behandlung von Entzündungserkrankungen mit Maracujaextrakten

Info

Publication number
DE602007005041D1
DE602007005041D1 DE602007005041T DE602007005041T DE602007005041D1 DE 602007005041 D1 DE602007005041 D1 DE 602007005041D1 DE 602007005041 T DE602007005041 T DE 602007005041T DE 602007005041 T DE602007005041 T DE 602007005041T DE 602007005041 D1 DE602007005041 D1 DE 602007005041D1
Authority
DE
Germany
Prior art keywords
passion fruit
treatment
inflammatory diseases
fruit extracts
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007005041T
Other languages
English (en)
Inventor
Lai Yeap Foo
Yinrong Lu
Ronald Ross Watson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IND RES Ltd
Industrial Research Ltd
Southwest Scient Editing & Con
Original Assignee
IND RES Ltd
Industrial Research Ltd
Southwest Scient Editing & Con
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IND RES Ltd, Industrial Research Ltd, Southwest Scient Editing & Con filed Critical IND RES Ltd
Publication of DE602007005041D1 publication Critical patent/DE602007005041D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Plant Substances (AREA)
DE602007005041T 2006-05-04 2007-05-04 Verfahren zur Behandlung von Entzündungserkrankungen mit Maracujaextrakten Active DE602007005041D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/417,721 US20060280821A1 (en) 2005-04-04 2006-05-04 Method of treating inflammation disorders using extracts of passion fruit

Publications (1)

Publication Number Publication Date
DE602007005041D1 true DE602007005041D1 (de) 2010-04-15

Family

ID=38319569

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007005041T Active DE602007005041D1 (de) 2006-05-04 2007-05-04 Verfahren zur Behandlung von Entzündungserkrankungen mit Maracujaextrakten

Country Status (8)

Country Link
US (1) US20060280821A1 (de)
EP (1) EP1854470B8 (de)
JP (1) JP4813418B2 (de)
AT (1) ATE459365T1 (de)
CA (1) CA2587126C (de)
DE (1) DE602007005041D1 (de)
ES (1) ES2342018T3 (de)
NZ (1) NZ554762A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2545975T3 (es) * 2009-04-03 2015-09-18 Morinaga & Co., Ltd. Composición que contiene piceatannol y procedimiento para producir la composición que contiene piceatannol
US20130171284A1 (en) 2010-06-28 2013-07-04 Yissum Research Development Company of the Hebrew University of Jerualem Ltd. Neuroprotective Natural Extract from Passion Fruit
JP6356492B2 (ja) * 2014-05-28 2018-07-11 森永製菓株式会社 抗炎症剤
CN104397621A (zh) * 2014-12-12 2015-03-11 广西职业技术学院 西番莲果皮罐头
KR101976202B1 (ko) 2017-10-23 2019-05-08 안동대학교 산학협력단 패션후르츠 과피 추출물을 유효성분으로 함유하는 혈전증의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품
KR102254421B1 (ko) 2017-12-05 2021-05-20 성화정 패션후르츠 과육과 씨의 혼합 추출물을 유효성분으로 함유하는 혈전증의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품
JP2019196327A (ja) * 2018-05-09 2019-11-14 森永製菓株式会社 パッションフルーツ種子の抽出物を有効成分とする発毛促進剤、医薬、食品および化粧品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
JPH01172325A (ja) * 1987-12-28 1989-07-07 Terumo Corp 抗リウマチ剤
JP3362494B2 (ja) * 1994-03-01 2003-01-07 三菱ウェルファーマ株式会社 ベンゾオキサジン化合物
US6544581B1 (en) * 1999-06-22 2003-04-08 Canandaigua Wine Company, Inc. Process for extraction, purification and enrichment of polyphenolic substances from whole grapes, grape seeds and grape pomace
US6818234B1 (en) * 1999-08-27 2004-11-16 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
US6555142B1 (en) * 2002-07-01 2003-04-29 Lonny S. Green Food supplement formulation
US6605306B1 (en) * 2002-07-01 2003-08-12 Lonny S. Green Food supplement formulation
EP1763360A4 (de) 2004-04-02 2009-08-19 Ind Res Ltd L L C Extrakte aus der passionsfrucht und ihre verwendungen

Also Published As

Publication number Publication date
ATE459365T1 (de) 2010-03-15
JP4813418B2 (ja) 2011-11-09
CA2587126C (en) 2013-04-09
ES2342018T3 (es) 2010-06-30
EP1854470B8 (de) 2010-05-19
EP1854470A1 (de) 2007-11-14
NZ554762A (en) 2008-12-24
EP1854470B1 (de) 2010-03-03
US20060280821A1 (en) 2006-12-14
JP2007302659A (ja) 2007-11-22
CA2587126A1 (en) 2007-11-04

Similar Documents

Publication Publication Date Title
DE602007005041D1 (de) Verfahren zur Behandlung von Entzündungserkrankungen mit Maracujaextrakten
WO2007128761A3 (de) Verwendungen von dpp iv inhibitoren
WO2010070675A8 (en) Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
JO2576B1 (en) Antibodies
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
SG10201803862UA (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
WO2006033734A3 (en) Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders
WO2008096203A3 (en) Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders
ATE453642T1 (de) Substituierte phenylaminopyrimidine
WO2010017196A3 (en) Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
FR2969495B1 (fr) Extrait de parties aeriennes de maca riche en polyphenols et composition le comprenant
GT200600115A (es) Metodo para identificar blancos terapeuticos para el tratamiento de atrofia vulvoginal
WO2009079451A3 (en) Compositions and methods of promoting wound healing
WO2007098142A3 (en) Oxazole ketones as modulators of fatty acid amide hydrolase
WO2008029169A3 (en) Method of treating respiratory disorders
DE502006002773D1 (de) Verwendung von Pelargonium Extrakten in Kombination mit Plantago zur Herstellung eines Medikaments zur Behandlung der Rachenentzündung
EP1844779A3 (de) Tergurid/Protergurid zur Behandlung von chronischen Schmerzen (z.B. Migräne)
BR0312696A (pt) Tratamento tópico de doenças da pele
DE502005010502D1 (de) Pharmazeutische Zusammensetzung, Verwendung dieser pharmazeutischen Zusammensetzung zur Herstellung eines Medikaments und/oder eines Nahrungsergänzungmittels zur Behandlung von Übergewicht und/oder Symptomen, die mit Übergewicht einhergehen, beim Menschen oder Säugetier, sowie Verfahren zur Herstellung dieser pharmazeutischen Zusammensetzung
WO2006079068A3 (en) Compositions and methods for studying and treating inflammatory diseases and disorders
WO2007106909A3 (en) Method of using pomegranate extracts for increasing prostate specific antigen doubling time
WO2011091154A3 (en) Use of human erythrocytes for prevention and treatment of cancer dissemination and growth
WO2006134135A3 (en) Nutritional method for elderly people
WO2008067056A3 (en) Method of inhibiting coagulation with human anti-factor va antibodies and use thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition